Anti-NF-kappaB p65 (Phospho-S529) Antibody 
Datasheet
MSDS
Description: Rabbit polyclonal antibody to NF-kappaB p65 (Phospho-S529) Immunogen: KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding S529 of human NF-kappaB p65 protein. The exact sequence is proprietary. Purification: The antibody was purified by immunogen affinity chromatography. Clonality: Polyclonal Form: Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide. Dilution: WB (1/500 - 1/1000), IH (1/50 - 1/100) Gene Symbol: RELA Alternative Names: NFKB3; Transcription factor p65; Nuclear factor NF-kappa-B p65 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3Entrez Gene (Human): 5970SwissProt (Human): Q04206Storage/Stability : Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of NF-kappaB p65 (Phospho-S529) expression in MCF7 (A), MCF7 TNFa treated 5 min (B), MCF7 TNFa treated 30 min (C), HEK293T (D), Hela (E) whole cell lysates. -
Immunohistochemical analysis of NF-kappaB p65 (Phospho-S529) staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Activation of the NF-?B pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells
CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules
WIP1 phosphatase is a negative regulator of NF-kappaB signalling